Cargando…

Construction and validation of a metabolism-associated gene signature for predicting the prognosis, immune landscape, and drug sensitivity in bladder cancer

Tumor Metabolism is strongly correlated with prognosis. Nevertheless, the prognostic and therapeutic value of metabolic-associated genes in BCa patients has not been fully elucidated. First, in this study, metabolism-related differential expressed genes DEGs with prognostic value in BCa were determi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Chong, Bi, Yuxin, Chai, Wang, Zhang, Zhe, Yang, Shaobo, Liu, Yuejiao, Wu, Zhouliang, Peng, Fei, Fan, Zhenqian, Hu, Hailong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601123/ https://www.ncbi.nlm.nih.gov/pubmed/37880682 http://dx.doi.org/10.1186/s12920-023-01678-6

Ejemplares similares

Identification and validation of a dysregulated TME-related gene signature for predicting prognosis, and immunological properties in bladder cancer
por: Shen, Chong, et al.
Publicado: (2023)

Identification of a dysregulated CircRNA-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancer
por: Shen, Chong, et al.
Publicado: (2022)

Comprehensive characterization of endoplasmic reticulum stress in bladder cancer revealing the association with tumor immune microenvironment and prognosis
por: Lin, Yuda, et al.
Publicado: (2023)

Pan-cancer analyses of clinical prognosis, immune infiltration, and immunotherapy efficacy for TRPV family using multi-omics data
por: Shen, Chong, et al.
Publicado: (2023)

Withdrawal notice to: “Pan-cancer analyses of clinical prognosis, immune infiltration, and immunotherapy efficacy for TRPV family using multi-omics data” [Heliyon 9, (2023) 16897]
por: Shen, Chong, et al.
Publicado: (2023)

Construction and experimental validation of a B cell-related gene signature to predict the prognosis and immunotherapeutic sensitivity in bladder cancer
por: Zhou, Ranran, et al.
Publicado: (2023)

Downregulated hsa_circ_0077837 and hsa_circ_0004826, facilitate bladder cancer progression and predict poor prognosis for bladder cancer patients
por: Shen, Chong, et al.
Publicado: (2020)

Long noncoding RNAs, ENST00000598996 and ENST00000524265, are correlated with favorable prognosis and act as potential tumor suppressors in bladder cancer
por: Shen, Chong, et al.
Publicado: (2020)

Construction of an Epithelial-Mesenchymal Transition-Related Model for Clear Cell Renal Cell Carcinoma Prognosis Prediction
por: Zhu, Shimiao, et al.
Publicado: (2022)

Identification of a Prognosis-Related Risk Signature for Bladder Cancer to Predict Survival and Immune Landscapes
por: Wang, Linhui, et al.
Publicado: (2021)

Construction and Validation of a 6-Ferroptosis Related Gene Signature for Prognosis and Immune Landscape Prediction in Melanoma
por: Yue, Zhanghui, et al.
Publicado: (2022)

Construction and Validation of a Novel Eight-Gene Risk Signature to Predict the Progression and Prognosis of Bladder Cancer
por: Wang, Ruiliang, et al.
Publicado: (2021)

AB175. Girdin protein is a novel prognosis predictor for patients with non-muscle invasive bladder cancer
por: Wu, Zhouliang, et al.
Publicado: (2016)

Construction and validation of an aging‐related gene signature for prognosis prediction of patients with breast cancer
por: Li, Jian, et al.
Publicado: (2022)

Construction of a telomere-related gene signature to predict prognosis and immune landscape for glioma
por: Xie, Qin, et al.
Publicado: (2023)

Construction and validation of a histone acetylation-related lncRNA prognosis signature for ovarian cancer
por: Hu, Xiao-Qian, et al.
Publicado: (2022)

A novel signature constructed by differential genes of muscle-invasive and non-muscle-invasive bladder cancer for the prediction of prognosis in bladder cancer
por: Wang, Weizhuo, et al.
Publicado: (2023)

Construction and validation of an eight-gene signature with great prognostic value in bladder cancer
por: Yan, Xin, et al.
Publicado: (2020)

Construction and Validation of an Autophagy-Related Prognostic Signature and a Nomogram for Bladder Cancer
por: Yan, Xin, et al.
Publicado: (2021)

Construction and Validation of a 13-Gene Signature for Prognosis Prediction in Medulloblastoma
por: Li, Chang, et al.
Publicado: (2020)

Construction and validation of a novel gene signature for predicting the prognosis of osteosarcoma
por: Yang, Jinpo, et al.
Publicado: (2022)

Constructing an immune‐ and ferroptosis‐related lncRNA signature to predict the immune landscape of human bladder cancer
por: Li, Xing, et al.
Publicado: (2022)

Construction of cuproptosis-related gene signature to predict the prognosis and immunotherapy efficacy of patients with bladder cancer through bioinformatics analysis and experimental validation
por: Liu, Zijian, et al.
Publicado: (2022)

Construction of a diagnostic signature and immune landscape of pulmonary arterial hypertension
por: Duo, Mengjie, et al.
Publicado: (2022)

Construction of an Immunophenoscore-Related Signature for Evaluating Prognosis and Immunotherapy Sensitivity in Ovarian Cancer
por: Jiang, Haonan, et al.
Publicado: (2023)

Construction of a ferroptosis-related signature based on seven lncRNAs for prognosis and immune landscape in clear cell renal cell carcinoma
por: Wei, Shi-Yao, et al.
Publicado: (2022)

Novel chemokine related LncRNA signature correlates with the prognosis, immune landscape, and therapeutic sensitivity of esophageal squamous cell cancer
por: Zhang, Zhe, et al.
Publicado: (2023)

Development of a Ferroptosis-Related lncRNA Signature to Predict the Prognosis and Immune Landscape of Bladder Cancer
por: Zhou, Ranran, et al.
Publicado: (2021)

A novel cuproptosis-related lncRNA signature predicts the prognosis and immune landscape in bladder cancer
por: Bai, Yuchen, et al.
Publicado: (2022)

Construction and validation of an aging-related gene signature predicting the prognosis of pancreatic cancer
por: Wang, Dengchuan, et al.
Publicado: (2023)

Construction and validation of a prognosis signature based on the immune microenvironment in gastric cancer
por: Wu, Li-Hong, et al.
Publicado: (2023)

Construction of a cuproptosis‐related lncRNA signature for predicting prognosis and immune landscape in osteosarcoma patients
por: Ni, Shumin, et al.
Publicado: (2022)

Identification and validation of a novel signature for prediction the prognosis and immunotherapy benefit in bladder cancer
por: Zhang, Yichi, et al.
Publicado: (2022)

Construction and validation of a necroptosis-related lncRNAs prognosis signature of hepatocellular carcinoma
por: Peng, YunZhen, et al.
Publicado: (2022)

Machine learning to construct sphingolipid metabolism genes signature to characterize the immune landscape and prognosis of patients with uveal melanoma
por: Chi, Hao, et al.
Publicado: (2022)

Identification and validation of tumor-infiltrating lymphocyte-related prognosis signature for predicting prognosis and immunotherapeutic response in bladder cancer
por: Li, Canxuan, et al.
Publicado: (2023)

Identification and validation of an anoikis-related lncRNA signature to predict prognosis and immune landscape in osteosarcoma
por: Zhang, Jun-Song, et al.
Publicado: (2023)

Construction and validation of a cuproptosis-related five-lncRNA signature for predicting prognosis, immune response and drug sensitivity in breast cancer
por: Li, Chun, et al.
Publicado: (2023)

An HDAC9-associated immune-related signature predicts bladder cancer prognosis
por: Fu, Yang, et al.
Publicado: (2022)

An Immunosenescence-Related Gene Signature to Evaluate the Prognosis, Immunotherapeutic Response, and Cisplatin Sensitivity of Bladder Cancer
por: Zhou, Ranran, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2e9m5hfltdpld0tve8mboa47h3